JUNIOR CLAV Oral Suspension is a trusted pediatric antibiotic formulation containing Amoxycillin and Potassium Clavulanate, developed to combat a wide range of bacterial infections in children. The addition of clavulanate helps overcome beta-lactamase resistance, making JUNIOR CLAV Oral Suspension highly effective where standard antibiotics may fail.
JUNIOR CLAV Oral Suspension is commonly prescribed for respiratory tract infections, ear and sinus infections, urinary tract infections, skin infections, and other bacterial conditions in pediatric patients. Its palatable suspension form ensures better compliance among children while delivering dependable therapeutic outcomes.
Key Benefits:
✅ Broad-spectrum coverage against gram-positive and gram-negative bacteria
✅ Overcomes antibiotic resistance with clavulanate support
✅ Effective in respiratory, ENT, skin & urinary infections
✅ Child-friendly oral suspension for easy dosing
✅ Ensures faster recovery with reliable bacterial eradication
✅ Safe and well-tolerated for pediatric use under medical supervision
Key Ingredients:
- Amoxycillin: A penicillin-class antibiotic that inhibits bacterial cell wall synthesis, leading to effective bacterial elimination
• Potassium Clavulanate: A beta-lactamase inhibitor that protects amoxycillin from resistance and enhances its antibacterial spectrum
Why Choose JUNIOR CLAV Oral Suspension?
JUNIOR CLAV Oral Suspension offers a clinically proven combination trusted by pediatricians for effective infection control in children. With enhanced resistance protection, excellent tolerability, and reliable efficacy, JUNIOR CLAV stands as a dependable choice in pediatric antibacterial therapy. Manufactured under stringent quality standards of Riva Kenko Pharma, it ensures safety, consistency, and therapeutic confidence for everyday clinical practice.
Reviews
There are no reviews yet.